ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
November 22, 2021Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs... -
Heron Begins Phase 2 Clinical Study of Cinvanti for COVID-19
July 27, 2020Heron Therapeutics announced the initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating CINVANTI (aprepitant) injectable emulsion in early hospitalized patients with Coronavirus Disease 2019 (COVID-19).
Pharma Sources Insight January 2025
